Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Hormonal Control of the Ovarian Cycle

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparison of PCOS phenotypes in adolescent and young adult Mediterranean women with possible PCOS.

Journal of endocrinological investigation·2020

Same author

How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.

Journal of endocrinological investigation·2015

Same author

Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.

Human reproduction (Oxford, England)·2013

Same author

Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome.

Journal of endocrinological investigation·2013

Same author

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.

Human reproduction update·2011

Same author

Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.

Journal of endocrinological investigation·2010

Search research articles

Related Experiment Video

Updated: May 16, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

PCOS: metabolic impact and long-term management.

¹Androgen Excess and PCOS Society, DISMOT Department, University of Palermo, Italy. enricocarmina@libero.it

Minerva Ginecologica

|December 13, 2012

Summary

This summary is machine-generated.

Polycystic ovary syndrome (PCOS) increases cardiovascular risk in women. Individual risk assessment is crucial, as metabolic changes with age in PCOS require further study.

More Related Videos

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice

Published on: July 5, 2024

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Related Experiment Videos

Last Updated: May 16, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice

Published on: July 5, 2024

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Area of Science:

Endocrinology
Reproductive Health
Cardiovascular Medicine

Background:

Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 10% of reproductive-aged women.
PCOS is associated with increased risks of type II diabetes, cardiovascular diseases, and endometrial cancer.
While cardiovascular risk is elevated in women with PCOS, individual risk profiles vary and require assessment.

Purpose of the Study:

To investigate the changes in metabolic profiles of women with PCOS over time.
To better understand the relationship between aging, hormonal changes, and cardiovascular risk in PCOS patients.
To highlight the need for more data on the long-term metabolic health of women with PCOS.

Main Methods:

This study focuses on analyzing existing data and literature regarding metabolic changes in women with PCOS.
The research involves a review of current understanding of cardiovascular risk factors in relation to age and hormonal fluctuations in PCOS.
Further research is needed to collect comprehensive data on metabolic profiles across different age groups.

Main Results:

Women with PCOS exhibit an increased lifetime risk for several chronic conditions.
There is a noted discrepancy between cardiovascular risk in younger women with PCOS and actual postmenopausal events, potentially linked to hormonal shifts.
Current data on age-related metabolic changes in PCOS is insufficient.

Conclusions:

Individualized cardiovascular risk assessment is essential for women with PCOS.
Hormonal changes, particularly androgen function post-forties, may influence cardiovascular risk progression.
More research is critically needed to elucidate age-related metabolic alterations in women with PCOS.